AU6247996A - Use of substituted pentose or hexose derivates in the treatment of aids and aids related neoplastic disorders - Google Patents

Use of substituted pentose or hexose derivates in the treatment of aids and aids related neoplastic disorders

Info

Publication number
AU6247996A
AU6247996A AU62479/96A AU6247996A AU6247996A AU 6247996 A AU6247996 A AU 6247996A AU 62479/96 A AU62479/96 A AU 62479/96A AU 6247996 A AU6247996 A AU 6247996A AU 6247996 A AU6247996 A AU 6247996A
Authority
AU
Australia
Prior art keywords
aids
hexose
derivates
treatment
neoplastic disorders
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
AU62479/96A
Inventor
Ake Dahlgren
Attila Dahlgren
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
ISM INSTITUTE FOR SOCIO-MEDICAL RESEARCH
Original Assignee
ISM INST FOR SOCIO MEDICAL RES
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ISM INST FOR SOCIO MEDICAL RES filed Critical ISM INST FOR SOCIO MEDICAL RES
Publication of AU6247996A publication Critical patent/AU6247996A/en
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7024—Esters of saccharides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/16011—Human Immunodeficiency Virus, HIV
    • C12N2740/16034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/14011—Filoviridae

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Virology (AREA)
  • Mycology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Microbiology (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
AU62479/96A 1995-06-21 1996-06-20 Use of substituted pentose or hexose derivates in the treatment of aids and aids related neoplastic disorders Withdrawn AU6247996A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
SE9502265 1995-06-21
SE9502265A SE9502265D0 (en) 1995-06-21 1995-06-21 Use of substituted pentose or hexose derivatives as physiologically active substances and composition containing these
PCT/SE1996/000825 WO1997000685A1 (en) 1995-06-21 1996-06-20 Use of substituted pentose or hexose derivates in the treatment of aids and aids related neoplastic disorders

Publications (1)

Publication Number Publication Date
AU6247996A true AU6247996A (en) 1997-01-22

Family

ID=20398704

Family Applications (1)

Application Number Title Priority Date Filing Date
AU62479/96A Withdrawn AU6247996A (en) 1995-06-21 1996-06-20 Use of substituted pentose or hexose derivates in the treatment of aids and aids related neoplastic disorders

Country Status (3)

Country Link
AU (1) AU6247996A (en)
SE (1) SE9502265D0 (en)
WO (1) WO1997000685A1 (en)

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0296588A (en) * 1988-09-29 1990-04-09 Rikagaku Kenkyusho Sulfated oligosaccharide and relating substance thereof
US5116821A (en) * 1990-11-20 1992-05-26 The Procter & Gamble Company Sulfated glyceroglucolipids as inhibitors of bacterial adherence
JP2556236B2 (en) * 1991-08-29 1996-11-20 田辺製薬株式会社 Polysulfate of β-cyclodextrin derivative and process for producing the same

Also Published As

Publication number Publication date
SE9502265D0 (en) 1995-06-21
WO1997000685A1 (en) 1997-01-09

Similar Documents

Publication Publication Date Title
AU7623096A (en) Use of epinastine in the treatment of pain
AU7230196A (en) Pskh-1 ribozymes and uses in disease treatment
AU5687896A (en) Use of alpha 1L-agonists in the treatment of incontinence
HUP9800033A3 (en) Compositions for the treatment of dermatological disorders and methods for their use
AU3339897A (en) Sulphonamide derivatives and their use in the treatment of cns disorders
AU5576896A (en) Methods and formulations for modulating the human sexual response
AU5772196A (en) 3,4-disubstituted-phenylsulphonamides and their therapeutic use
AU3725997A (en) S(-)-tolterodine in the treatment of urinary and gastrointestinal disorders
AU4054297A (en) Manipulations of nitrosative and oxidatives stress in the treatment of disease
AU5772296A (en) 3,4-disubstituted-phenylsulphonamides and their therapeutic use
PH31600A (en) Methods of inhibiting atrophy of the skin and vagina.
AU5772396A (en) 3,4-disubstituted-phenylsulphonamides and their therapeutic use
AU3959193A (en) Heterocyclic compounds and their use in the treatment of type II-diabetes
AU2466695A (en) The use of famotidine and related compounds in the treatment of movement disorders
AU5135296A (en) Use of protealytic enzymes in the treatment of insect bites
AU5590696A (en) Use of quinones in the treatment of cancer or AIDS
AU3300689A (en) Treatment of inflammatory disorders in humans
AU7384094A (en) Use of phenethanolamine derivatives in the treatment of gastrointestinal disorders
AU3099997A (en) The use of tcet in the prophylaxis and treatment of allergies
AU6369094A (en) Ige isoforms and methods of use
AU7529796A (en) S-nitroso-hemoglobin and therapeutic uses thereof
AU4812393A (en) Use of rapamycin in the treatment of aids
AUPN104895A0 (en) Methods of and preparations for the treatment of ailments and disorders
ZA969586B (en) The use of cholinesterase inhibitors in the treatment of xerostomia
AU6247996A (en) Use of substituted pentose or hexose derivates in the treatment of aids and aids related neoplastic disorders